Список литературы

1. Андреева НС, Реброва ОЮ, Зорин НА Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. Медицинские технологии Оценка и выбор 2012;4:10–24.

2. Rahimtoola SH Foreword. Curr Probl Cardiol 2009 Mar;34:89.

3. Земцовский ЭВ, Малев ЭГ, Березовская ГА, Парфенова НН, Реева СВ, Лунева ЕБ, et al. Наследственные нарушения соединительной ткани в кардиологии. Диагностика и лечение Российские рекомендации (I пересмотр). Российский кардиологический журнал  2013;1:1–32.

4. Carpentier A. Congenital malformations of the mitral valve Surgery for congenital heart defects. W. B. Saunders Philadelphia , 1994, 1994.

5. Бокерия ЛА, Ким АИ, Абдувохидов БУ, Серов РА, Лашнева АС Хирургическая анатомия митрального клапана у детей раннего возраста. Детские болезни сердца и сосудов 2012 [cited 2018 May 30];37–44.

6. Белоконь НА, Подзолков ВП Врожденные пороки сердца. Медицина Москва, 1991, 1990, [cited 2021 May 28].Available from: http://padabum.com/d.php?id=40831

7. Rothenburger M, Rukosujew A, Hammel D, Dorenkamp A, Schmidt C, Schmid C, et al. Mitral valve surgery in patients with poor left ventricular function. Thorac Cardiovasc Surg 2002 Dec;50:351–354.

8. Bonow RO, Carabello B, De Leon J, Edmunds J, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). Circulation 1998 Nov 3;98:1949–1984.

9. Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, et al. Mitral valve prolapse in the general population: The benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002 Oct 2;40:1298–1304.

10. Земцовский ЭВ, Малев ЭГ, Реева СВ Пролапс митрального клапана: “много шума из ничего” или реальная и нерешенная проблема? Кардиоваскулярная терапия и профилактика 2010 [cited 2021 Sep 7];9:69–74.

11. Park SM, Park SW, Casaclang-Verzosa G, Ommen SR, Pellikka PA, Miller FA, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial. Am Heart J 2009;157:762.e3-762.e10.

12. Pederzolli N, Agostini F, Fiorani V, Tappainer E, Nocchi A, Manfredi J, et al. Postendocarditis mitral valve aneurysm. J Cardiovasc Med 2009 Mar;10:259–260.

13. Carpentier A, Adams DH, Filsoufi F Carpentier’s Reconstructive Valve Surgery - 1st Edition. Missouri: Saunders 2010;5–167.

14. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35-e71.

15. DaCruz EM, Ivy D, Jaggers J Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. London, Springer London, 2014. DOI: 10.1007/978-1-4471-4619-3

16. Boudoulas H, Kolibash AJ, Baker P, King BD, Wooley CF Mitral valve prolapse and the mitral valve prolapse syndrome: A diagnostic classification and pathogenesis of symptoms. Am Heart J 1989;118:796–818.

17. Чазова ИЕ, Мартынюк ТВ, Валиева ЗС, Азизов ВА, Барбараш ОЛ, Веселова ТН, et al. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал 2020 Mar 30;0:78–122.

18. Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP Procalcitonin and the Early Diagnosis of Infective Endocarditis. Circulation 2004 Apr 13;109:1707–1710.

19. Knudsen JB, Fuursted K, Petersen E, Wierup P, Mølgaard H, Poulsen SH, et al. Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med 2010 Dec;123:1121–1127.

20. Kocazeybek B, Küçükoǧlu S, Öner YA Procalcitonin and C-reactive protein in infective endocarditis: Correlation with etiology and prognosis. Chemotherapy 2003;49:76–84.

21. Habib G, Lancellotti P, Antunes M, Bongiorni M, Casalta J, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015 Nov 21;36:3075–3123.

22. Naderi H, Abbara A, Viviano A, Asaria P, Pabari P, Flora R, et al. Re-emphasising the importance of histopathological diagnosis in suspected bacterial endocarditis. Perfusion 2021 Aug 11;026765912110388.

23. Gupta S, Sakhuja A, McGrath E, Asmar B Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States. Congenit Heart Dis 2017 Mar 1;12:196–201.

24. Mahony M, Lean D, Pham L, Horvath R, Suna J, Ward C, et al. Infective Endocarditis in Children in Queensland, Australia: Epidemiology, Clinical Features and Outcome. Pediatr Infect Dis J 2021 Jul 1;40:617–622.

25. Luca A, Curpan A, Adumitrachioaiei H, Ciobanu I, Dragomirescu C, Manea R, et al. Difficulties in Diagnosis and Therapy of Infective Endocarditis in Children and Adolescents-Cohort Study. Healthc (Basel, Switzerland) 2021 Jun 1;9. DOI: 10.3390/HEALTHCARE9060760

26. Терещенко СН, Жиров ИВ, Ускач ТМ, Саидова МА, Голицын СП, Гупало ЕМ., et al. Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК)/ национального общества по изучению сердечной недостаточности и заболеваний миокарда (НОИСН) по диагностике и лечению хронической сердечной недостаточности (2020). Евразийский кардиологический журнал  2020 Sep 30;6–76.

27. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017 Sep 21;38:2739–2786.

28. Nishimura RA, O’Gara PT, Bavaria JE, Brindis RG, Carroll JD, Kavinsky CJ, et al. 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2019 May 28;73:2609–2635.

29. Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2017 Oct 1;52:616–664.

30. Gripari P, Muratori M, Fusini L, Tamborini G, Pepi M Three-dimensional echocardiography: Advancements in qualitative and quantitative analyses of mitral valve morphology in mitral valve prolapse. J Cardiovasc Echogr 2014;24:1–9.

31. Sachdeva R, Valente A, Armstrong A, Cook S, Han B, Lopez L, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society. J Am Soc Echocardiogr 2020 Oct 1;33:e1–e48.

32. Takahashi K, Mackie AS, Rebeyka IM, Ross DB, Robertson M, Dyck JD, et al. Two-Dimensional Versus Transthoracic Real-Time Three-Dimensional Echocardiography in the Evaluation of the Mechanisms and Sites of Atrioventricular Valve Regurgitation in a Congenital Heart Disease Population. J Am Soc Echocardiogr 2010 Jul;23:726–734.

33. Cantinotti M, Giordano R, Koestenberger M, Voges I, Santoro G, Franchi E, et al. Echocardiographic examination of mitral valve abnormalities in the paediatric population: current practices. Cardiol Young 2020;30:1–11.

34. Takahashi K, Mackie A, Rebeyka I, Ross D, Robertson M, Dyck J, et al. Two-dimensional versus transthoracic real-time three-dimensional echocardiography in the evaluation of the mechanisms and sites of atrioventricular valve regurgitation in a congenital heart disease population. J Am Soc Echocardiogr 2010 Jul;23:726–734.

35. Castello R, Fagan L, Lenzen P, Pearson AC, Labovitz AJ Comparison of transthoracic and transesophageal echocardiography for assessment of left-sided valvular regurgitation. Am J Cardiol 1991 Dec 15;68:1677–1680.

36. Бокерия ЛА, Голухова ЕЗ, Машина ТВ Трехмерная эхокардиография. НЦ ССХ им. 2002.

37. Adams DH, Rosenhek R, Falk V Degenerative mitral valve regurgitation: Best practice revolution. Eur Heart J 2010 Aug;31. DOI: 10.1093/eurheartj/ehq222

38. Agricola E, Oppizzi M, Pisani M, Maisano F, Margonato A Accuracy of real-time 3D echocardiography in the evaluation of functional anatomy of mitral regurgitation. Int J Cardiol 2008 Jul 21;127:342–349.

39. La Canna G, Arendar I, Maisano F, Monaco F, Collu E, Benussi S, et al. Real-time three-dimensional transesophageal echocardiography for assessment of mitral valve functional anatomy in patients with prolapse-related regurgitation. Am J Cardiol 2011 May 1;107:1365–1374.

40. Sagie A, Freitas N, Chen MH, Marshall JE, Weyman AK, Levine RA Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse. J Am Soc Echocardiogr 1997;10:141–148.

41. Cantinotti M, Giordano R, Emdin M, Assanta N, Crocetti M, Marotta M, et al. Echocardiographic assessment of pediatric semilunar valve disease. Echocardiography 2017 Sep 1;34:1360–1370.

42. Ben Zekry S, Nagueh SF, Little SH, Quinones MA, McCulloch ML, Karanbir S, et al. Comparative accuracy of two- and three-dimensional transthoracic and transesophageal echocardiography in identifying mitral valve pathology in patients undergoing mitral valve repair: Initial observations. J Am Soc Echocardiogr 2011 Oct;24:1079–1085.

43. Shernan SK Perioperative transesophageal echocardiographic evaluation of the native mitral valve. Crit Care Med 2007 Aug;35. DOI: 10.1097/01.CCM.0000270248.34274.AB

44. Carabello BA, Nolan SP, McGuire LB Assessment of preoperative left ventricular function in patients with mitral regurgitation: Value of the end-systolic wall stress-end-systolic volume ratio. Circulation 1981;64:1212–1217.

45. Enriquez-Sarano M, Schaff H V., Orszulak TA, Tajik AJ, Bailey KR, Frye RL Valve repair improves the outcome of surgery for mitral regurgitation: A multivariate analysis. Circulation 1995 Feb 15;91:1022–1028.

46. Enriquez-Sarano M, Tribouilloy C Quantitation of mitral regurgitation: Rationale, approach, and interpretation in clinical practice. Heart 2002;88. DOI: 10.1136/heart.88.suppl_4.iv1

47. Simonson JS, Schiller NB Sonospirometry: A new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration. J Am Coll Cardiol 1988;11:557–564.

48. Simpson J, Lopez L, Acar P, Friedberg MK, Khoo NS, Ko HH, et al. Three-dimensional Echocardiography in Congenital Heart Disease: An Expert Consensus Document from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2017 Jan 1;30:1–27.

49. Bharucha T, Roman KS, Anderson RH, Vettukattil JJ Impact of Multiplanar Review of Three-Dimensional Echocardiographic Data on Management of Congenital Heart Disease. Ann Thorac Surg 2008 Sep;86:875–881.